Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities    
Net income (loss) $ 151,492 $ 38,120
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for loss on receivables (2,177) 2,689
Depreciation and amortization 515 1,862
Amortization of financing costs 8,192 6,318
Equity-based compensation 14,884 11,478
Equity method investments (161,958) (6,355)
Non-cash gain on securitization (53,891) (14,603)
(Gain) loss on sale of receivables and investments 8,532 1,305
Changes in receivables held-for-sale (6,750) 51,538
Changes in accounts payable and accrued expenses 50,801 (9,733)
Change in accrued interest on receivables and investments (33,242) (14,518)
Cash received (paid) upon hedge settlement 19,261 0
Other 455 (2,375)
Net cash provided by (used in) operating activities (3,886) 65,726
Cash flows from investing activities    
Equity method investments (168,896) (429,944)
Equity method investment distributions received 11,426 4,203
Proceeds from sales of equity method investments 2,107 0
Purchases of and investments in receivables (347,343) (317,805)
Principal collections from receivables 470,788 74,328
Proceeds from sales of receivables 99,166 7,634
Proceeds from sale of real estate 115,767 0
Purchases of investments and securitization assets 0 (12,969)
Posting of hedge collateral (1,140) (13,380)
Receipt of hedge collateral 4,010 0
Other (680) (473)
Net cash provided by (used in) investing activities 185,205 (688,406)
Cash flows from financing activities    
Proceeds from credit facilities 616,792 467,000
Principal payments on credit facilities (701,792) (235,000)
Proceeds from issuance of term loan 250,000 0
Proceeds from issuance of term loan 250,000 0
Principal payments on term loan (561,023) (4,788)
Proceeds from issuance of commercial paper notes 80,000 100,000
Proceeds from issuance of senior unsecured notes 205,500 0
Net proceeds of common stock issuances 82,014 357,594
Payments of dividends and distributions (93,280) (72,129)
Withholdings on employee share vesting (466) (1,433)
Payment of financing costs (19,711) (921)
Posting of hedge collateral (90,860) 0
Receipt of hedge collateral 114,700 0
Other (969) (1,768)
Net cash provided by (used in) financing activities (95,053) 598,486
Increase (decrease) in cash, cash equivalents, and restricted cash 86,266 (24,194)
Cash, cash equivalents, and restricted cash at beginning of period 75,082 175,972
Cash, cash equivalents, and restricted cash at end of period 161,348 151,778
Interest paid 110,097 68,167
Supplemental disclosure of non-cash activity    
Residual assets retained from securitization transactions 28,164 26,020
Equity method investments retained from securitization transactions 32,564 0
Equity method investments retained from sale of assets upon establishment of co-investment structure 54,655 0
Deconsolidation of non-recourse debt 51,233 32,923
Deconsolidation of assets pledged for non-recourse debt 51,761 31,371
Non-recourse debt    
Cash flows from financing activities    
Proceeds from issuance of non-recourse debt 94,000 0
Principal payments on non-recourse debt $ (69,958) $ (10,069)